about
Isolation of a novel member of small G protein superfamily and its expression in colon cancerTargeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3'-UTR microRNAKnockdown of DNA methyltransferase-1 inhibits proliferation and derepresses tumor suppressor genes in myeloma cells.Activation of GluR6-containing kainate receptors induces ubiquitin-dependent Bcl-2 degradation via denitrosylation in the rat hippocampus after kainate treatmentTargeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis.Bcl-2 overexpression enhances tumor-specific T-cell survivalMolecular control of bacterial death and lysisCharacterization of a Dual CDC7/CDK9 Inhibitor in Multiple Myeloma Cellular ModelsStimulatory heterotrimeric G protein augments gamma ray-induced apoptosis by up-regulation of Bak expression via CREB and AP-1 in H1299 human lung cancer cells.Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma.FKBP38 protects Bcl-2 from caspase-dependent degradation.Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells.Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma.Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.Germline BCL-2 sequence variants and inherited predisposition to prostate cancer.Oxidative and nitrosative stress in the metastatic microenvironment.Bortezomib mitigates adverse prognosis conferred by Bcl-2 overexpression in patients with relapsed/refractory multiple myeloma.Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.Down-regulation of glutathione and Bcl-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium.Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination.
P2860
Q28201755-1BBAFAD0-E020-4D7F-A70F-1D522B5C2BCBQ34076762-760F45EC-273B-48DD-BF39-112F5AC2C0B0Q34293113-6670EAB5-A73B-4E13-BA68-E364D1B8D2E0Q34606468-02DF1A81-F639-4FBB-A836-C8E3498C2A6BQ35782897-2833220F-D612-4FEE-B1BF-699CB7E50C35Q36327125-1B7FA4F5-0323-482B-B404-C26B3ABE0630Q36497703-8DDCCB7C-BE0D-41C1-ADCC-47C45AE4D26FQ37226506-36C6CC73-A68B-4D23-8055-781E4EF72741Q37337906-5EE99D16-D07F-4356-8CB8-160166913585Q39308923-6A3BEFE4-7D88-4556-A0A5-9EA11620CBCFQ39738865-4907A5BE-1B27-4B77-AE90-51744EB488DAQ40203508-2913C2A7-F9C2-4B11-9590-36977E1B8B3FQ41770950-E6F2FB9F-69BB-40F0-A864-BD482F6924DBQ41812863-5488B883-4D4C-426F-A86C-C05577D07CAAQ42686862-BB77BC92-B555-48BA-BCE5-B4D48F65BCB0Q42875853-118E19E8-AB50-460E-84C6-66DB7B3ADE53Q43626781-F2004A26-5CD3-4C7E-AF2B-D1032C848D08Q43670982-EB82DA3D-70EC-492F-9AD8-B034A0018AF1Q44526097-1CB28E7C-44E0-4968-B4E8-6BB774371E5CQ45010004-07C09709-1246-4B6A-BEEC-2BD4C676C381
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Role of Bcl-2 family of proteins in malignancy.
@ast
Role of Bcl-2 family of proteins in malignancy.
@en
Role of Bcl-2 family of proteins in malignancy.
@nl
type
label
Role of Bcl-2 family of proteins in malignancy.
@ast
Role of Bcl-2 family of proteins in malignancy.
@en
Role of Bcl-2 family of proteins in malignancy.
@nl
prefLabel
Role of Bcl-2 family of proteins in malignancy.
@ast
Role of Bcl-2 family of proteins in malignancy.
@en
Role of Bcl-2 family of proteins in malignancy.
@nl
P2860
P356
P1476
Role of Bcl-2 family of proteins in malignancy.
@en
P2093
Belinda C Baliga
P2860
P356
10.1002/HON.685
P50
P577
2002-06-01T00:00:00Z